Vasoactive substances regulate vascular smooth muscle cell apoptosis: Countervailing influences of nitric oxide and angiotensin II

Circulation Research

Volumn 79, Issue 4, 1996, Pages 748-756

  Pollman, Matthew J ^a   Yamada, Takehiko ^a   Horiuchi, Masatsugu ^a   Gibbons, Gary H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cGMP; guanylate cyclase; programmed cell death; vascular remodeling; vasoactive substances

Indexed keywords

ANGIOTENSIN; GUANYLATE CYCLASE; NITRIC OXIDE; PHOSPHODIESTERASE; VASOACTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; DNA SYNTHESIS INHIBITION; ENZYME INHIBITION; GENE INDUCTION; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; RABBIT; SECOND MESSENGER; VASCULAR SMOOTH MUSCLE;

EID: 0029820256     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.4.748     Document Type: Article

References (41)

1. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431-1438.
2. Gibbons GH. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors. Curr Opinion Nephrol Hypertens. 1995;4:189-196.
3. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
4. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
5. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
6. von der Leyen H, Gibbons GH, Morishita R, Lewis NP, Zhang L, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
7. Morishita R, Gibbons GH, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Novel and effective gene transfer technique for the study of vascular renin angiotensin system. J Clin Invest. 1994;94:978-984.
8. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
9. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1-β -converting enzyme. Am J Pathol 1995;147:251-266.
10. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
11. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal Iamb. Circ Res. 1995;76:168-175.
12. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
13. Raff M. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
14. Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168:1194-1200.
15. Bennett MR, Evan GI, Newby AC. Deregulated expression of the cmyc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-γ, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 1994;74:525-536.
16. Bennett MR, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
17. Strauss WM. Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. New York, NY: John Wiley & Sons Inc; 1995;1:2.1-3.1.
18. Tilly JL, Hsueh AJW. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol. 1993;154:519-526.
19. Sherwood SW, Shimke RT. Cell cycle analysis for apoptosis using flow cytometry. Methods Cell Biol. 1995;46:77-97.
20. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Shulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci U S A. 1992;89:5408-5412.
21. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res. 1978;9:145-158.
22. Trindade P, Hutchinson HG, Pollman MJ, Gibbons GH, Pratt RE. Atrial natriuretic peptide and C-type natriuretic peptide induce apoptosis in vascular smooth muscle cells. Circulation. 1995;92(suppl I):I-696. Abstract.
23. Kato J, Misko TP, Currie MG. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells. Eur J Pharmacol. 1993;244:153-159.
24. Lugnier C, Schini VB. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem Pharmacol. 1990;39:75-84.
25. Frodsham G, Jones RB. Effect of flosequinan upon isoenzymes of phosphodiesterase from guinea-pig cardiac and vascular smooth muscle. Eur J Pharmacol. 1992;211:383-391.
26. 2+ current modulated by cGMP-dependent protein kinase. Nature. 1994;369:336-339.
27. Sekhar KR, Hatchett RJ, Shabb JB, Wolfe L, Francis SH, Wells JW, Jastorff B, Butt E, Chakinala MM, Corbin JD. Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase. Mol Pharmacol. 1992;42:103-108.
28. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
29. Gonczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia. 1993;7:659-670.
30. Pollman MJ, Sherwood SW, Gibbons GH. Cell cycle arrest induces vascular smooth muscle cell programmed cell death: implications for amiprol iterative therapies in restenosis. Circulation. 1995;90(suppl I):I-101. Abstract
31. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol. 1995;146:3-15.
32. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 1991;32:223-254.
33. + channel of vascular smooth muscle cells. FEBS Lett. 1994;345:47-49.
34. Ichimori K, Ishida H, Fukahori M, Nakazawa H, Murakami E. Practical nitric oxide measurement employing a nitric oxide-selective electrode. Rev Sci Instrum. 1994;65:1-5.
35. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vase Biol. 1996;16:19-27.
36. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993;150:5080-5085.
37. Blanco FJ, Ochs RL, Schwartz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995;146:75-85.
38. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-1146.
39. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Circ Res. 1993;73:217-222.
40. Griendling KK, Alexander RW. The angiotensin (ATI) receptor. Semin Nephrol. 1993;13:558-66.
41. Yamada T, Horiuchi M, Dzau VJ. The novel angiotensin type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93:156-160.